Manufacturer record
Aspo Pharmaceuticals LLP: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Aspo Pharmaceuticals LLP (Himachal Pradesh) were declared Not of Standard Quality between October 2023 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AT25-0938A, Aceclofenac, Paracetamol & Chlorzoxazone Tablets (exp Oct 2027). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to declared formula, in respect of content of Aceclofenac. Listed in the September 2026 alert.
Records by type
5 records linked to Aspo Pharmaceuticals LLP in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Batch AT25-0938AMfg Nov 2025 · Exp Oct 2027 | The sample does not conform to declared formula, in respect of content of Aceclofenac.Other | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Ambroxol, Terbutaline Guaiphenesin with Menthol Syrup | Batch AL24-0611AMfg Dec 2024 · Exp Nov 2026 | The sample does not conform to Manufacturer's Specification with respect to Assay of Ambroxol Hydrochloride, Guaiphenesin, and Terbutaline SulphateAssay | CDL, KolkataCDSCO lab | May 2026 |
| Diclofenac Potassium, Paracetamol & Chlorzoxazone Tablets. | Batch AT24-1055Mfg Nov 2024 · Exp Oct 2026 | Disintegration Test.Disintegration | DTL, BaddiState lab | Mar 2026 |
| Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP..(Pevicet M TABLETS) | Batch AT22-0667AMfg Sep 2022 · Exp Aug 2024 | Dissolution (Montelukast & Levocetirizine Dihydrochloride)Dissolution | RDTL GuwahatiState lab | Jan 2024 |
| SUCRALFATE & OXETACAINE SUSPENSION 1 gm + 10 mg (RANPURE SUSPENSION) | Batch AL23-0108Mfg Feb 2023 · Exp Jan 2025 | pH and Assay Content of OxetacineAssay | CDTL HyderabadCDSCO lab | Oct 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.